Leading Companies in the Global Sleep Apnea Devices Market 2025

Published Date : 2025-Mar-02

The global sleep apnea devices market is projected to grow significantly, driven by increasing awareness of sleep disorders, rising cases of obstructive sleep apnea (OSA), and technological advancements in CPAP, BiPAP, and other sleep therapy solutions. Below is an overview of the top companies leading the industry in 2025, including key details such as their headquarters, founding year, website, number of employees, revenue (2024), and regional presence.

Market size is poised to grow from $5.09 Billion in 2024 to $8.46 Billion by 2032, growing at a CAGR of 6.6 % in the forecast period (2024-2032).

Leading Companies Are: ResMedPhilips RespironicsFisher & PaykelSomnoMedBMC MedicalDrive DeVilbissBraebon Medical and Inspire Medical.


Leading Companies in the Market

ResMed Inc.

 

Headquarters: San Diego, California, USA
Founded: 1989
Employees: 8,000+ globally
Revenue (2024): Estimated $4.2 billion
Regional Presence: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Overview: Globus Medical is a U.S. based medical technology company specializing in spinal surgery, orthopedic implants, and robotic-assisted navigation systems. The company is a global leader in spine surgery innovation, with its ExcelsiusGPS® robotic navigation system revolutionizing minimally invasive spinal procedures.

ResMed operates in over 140 countries and remains at the forefront of sleep apnea treatment, continuously innovating to improve respiratory health worldwide.

 

Philips Respironics (Royal Philips)

 
Headquarters: Murrysville, Pennsylvania, USA
Founded: 1891 (Philips), Respironics acquired in 2007
Employees: 80,000+ (Royal Philips)
Revenue (2024): Estimated $19 billion (Philips Healthcare segment)
Regional Presence: Global, with strong presence in North America and Europe

Overview: Philips Respironics, a division of Royal Philips, is a leading provider of sleep and respiratory care solutions, particularly in the sleep apnea devices market. Known for its DreamStation series and advanced CPAP and BiPAP devices, the company plays a crucial role in improving sleep therapy for millions of patients worldwide.

Philips Respironics operates in over 100+ countries and remains a top competitor in the sleep apnea devices market, continuously innovating smart sleep solutions to enhance patient well-being globally.

 

Fisher & Paykel Healthcare

 

Headquarters: Auckland, New Zealand
Founded: 1934
Employees: 6,000+ (2024)
Revenue (2024): Estimated $2 billion
Regional Presence: North America, Europe, Asia-Pacific, Latin America

Overview: Fisher & Paykel Healthcare is a leading medical device manufacturer specializing in respiratory care, sleep apnea therapy, and critical care solutions. The company is known for its innovative CPAP (Continuous Positive Airway Pressure) devices, humidification systems, and masks, improving the lives of patients with sleep apnea and other respiratory disorders worldwide.

Fisher & Paykel Healthcare operates in over 120+ countries and continues to innovate and expand in the sleep apnea market, maintaining a stronghold in respiratory humidification and high-flow therapy.

 

SomnoMed

 

Headquarters: Sydney, Australia
Founded: 2004
Employees: 500+ (2024)
Revenue (2024): Estimated $120 million
Regional Presence: North America, Europe, Asia-Pacific

Overview: SomnoMed is a global leader in oral appliance therapy (OAT) for obstructive sleep apnea (OSA). Unlike traditional CPAP machines, SomnoMed specializes in custom-fitted mandibular advancement devices (MADs), offering non-invasive, comfortable, and clinically proven alternatives for patients who struggle with CPAP compliance.

SomnoMed is a leading alternative to CPAP therapy, targeting mild to moderate obstructive sleep apnea (OSA) patients who prefer non-invasive treatments.

SomnoMed is revolutionizing sleep apnea treatment by offering comfortable, non-invasive oral appliances, making it a key player in the evolving sleep apnea devices market.

 

BMC Medical

 

Headquarters: Beijing, China
Founded: 2001
Employees: 1,500+ (2024)
Revenue (2024): Estimated $400 million
Regional Presence: Asia-Pacific, North America, Europe, Middle East

Overview: BMC Medical is a China-based medical device company specializing in sleep apnea therapy and respiratory care solutions. Known for its affordable and high-quality CPAP, BiPAP, and sleep diagnostic devices, BMC Medical has established itself as a key competitor to ResMed, Philips Respironics, and Fisher & Paykel Healthcare, particularly in emerging markets.

BMC Medical is rapidly growing as a leading budget-friendly alternative to premium sleep apnea brands, making sleep therapy more accessible globally.

 

Drive DeVilbiss Healthcare

 

Headquarters: Port Washington, New York, USA
Founded: 1885
Employees: 1,000+ (2024)
Revenue (2024): Estimated $500 million
Regional Presence: North America, Europe, Asia-Pacific

Overview: Drive DeVilbiss Healthcare is a well-established medical device company, specializing in CPAP (Continuous Positive Airway Pressure) machines, BiPAP devices, oxygen therapy, and other respiratory care solutions. The company is recognized for offering affordable, high-quality sleep apnea treatment products, making it a key competitor in the global sleep therapy market.

Drive DeVilbiss Healthcare continues to innovate and expand, positioning itself as a cost-effective alternative to premium sleep apnea brands like ResMed and Philips Respironics.

 

Braebon Medical Corporation

 

Headquarters: Kanata, Ontario, Canada
Founded: 1998
Employees: 200+ (2024)
Revenue (2024): Estimated $100 million
Regional Presence: North America, Europe

Overview: Braebon Medical Corporation is a Canada-based medical device company specializing in sleep apnea diagnostics, home sleep testing, and therapy solutions. The company is well-known for its advanced monitoring systems, PSG (polysomnography) sensors, and compliance tracking devices, supporting sleep clinics, healthcare providers, and home-based sleep testing.

Braebon Medical Corporation focuses on enhancing sleep disorder diagnostics, working closely with sleep labs, hospitals, and telemedicine providers to deliver high-quality diagnostic and compliance monitoring solutions.

Braebon Medical Corporation is a key player in the sleep disorder diagnostics industry, focusing on advanced home sleep testing, PSG systems, and compliance monitoring solutions.

 

Inspire Medical Systems

 

Headquarters: Minneapolis, Minnesota, USA
Founded: 2007
Employees: 700+ (2024)
Revenue (2024): Estimated $700 million
Regional Presence: North America, Europe

Overview: Inspire Medical Systems is a U.S.-based medical technology company that specializes in implantable neurostimulation therapy for obstructive sleep apnea (OSA). Unlike traditional CPAP (Continuous Positive Airway Pressure) machines, Inspire’s FDA-approved Inspire Therapy is a surgically implanted device that stimulates the hypoglossal nerve to keep the airway open during sleep. This innovation has made Inspire a game-changer in the sleep apnea treatment market.

Inspire Medical Systems is revolutionizing sleep apnea treatment with innovative, implantable neurostimulation therapy, positioning itself as a disruptive force in the global sleep apnea devices market.

 

Regional Analysis of the Global Sleep Apnea Devices Market (2025)

North America (Largest Market)
  • The U.S. dominates the market due to high awareness of sleep disorders, advanced healthcare infrastructure, and reimbursement policies.
  • Major players: ResMed, Philips Respironics, Inspire Medical Systems.
Europe
  • Increasing government initiatives and rising adoption of CPAP and BiPAP devices.
  • Major players: Philips Respironics, Fisher & Paykel Healthcare, Braebon Medical.
Asia-Pacific (Fastest Growing Market)
  • Rising prevalence of sleep apnea due to lifestyle changes and increasing healthcare spending.
  • Major players: BMC Medical, Apex Medical, Fisher & Paykel Healthcare.
Latin America
  • Gradual market growth with increasing awareness and adoption of sleep apnea therapies.
  • Major players: ResMed, Philips Respironics.
Middle East & Africa
  • Emerging market with improving healthcare infrastructure.
  • Major players: Fisher & Paykel Healthcare, BMC Medical.

 

Conclusion

The global sleep apnea devices market is expanding rapidly, driven by innovation, increasing patient awareness, and the growing prevalence of sleep disorders. Companies such as ResMed, Philips Respironics, and Fisher & Paykel Healthcare continue to lead the industry with cutting-edge solutions, while emerging firms like Inspire Medical Systems are introducing new alternatives to CPAP therapy.

Would you like insights on market trends, technological advancements, or investment opportunities in this sector? Let me know!

 

Get This Full Report: https://bit.ly/4h4vWxy

 

About US:

Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

Contact Us: IMIR Market Research Pvt. Ltd.
Follow Us: LinkedIn
Email: sales@intellectualmarketinsights.com
Call Us: +1 (814) 487 8486

To Gain Further Insights on
this Market, Write Us: